Group 4:Nil

6 trials

Sponsors

The Third Affiliated Hospital of Sun Yat-Sen University, Harbin Institute of Hematology and Oncology, The Second Affiliated Hospital of Soochow University, Shanghai East Hospital, Shenzhen University General Hospital

Conditions

CIPNDiabetesLabor analgesiaNociceptive monitoring of anesthesia monitoringliver cancer

Early Phase 1

The clinical and immunological study of acupoint catgut embedding combined with intraspinal anesthesia for labor analgesia

Active, not recruitingITMCTR2000003203

The Third Affiliated Hospital of Sun Yat-Sen UniversityLabor analgesia

Start: 2021-01-01Updated: 2023-02-20

The clinical and immunological study of acupoint catgut embedding combined with intraspinal anesthesia for labor analgesia

Active, not recruitingChiCTR2000031807

The Third Affiliated Hospital of Sun Yat-Sen UniversityLabor analgesia

Start: 2021-01-01Updated: 2020-04-13

Ultrasonic measurement of pupil to observe the dose-effect relationship between different sufentanil doses and pupillary changes

RecruitingChiCTR2100043771

The Second Affiliated Hospital of Soochow UniversityNociceptive monitoring of anesthesia monitoring

Start: 2021-03-01Updated: 2021-06-28

The value of different indicators and treatment methods in the clinical application of diabetes

RecruitingChiCTR2100047148

Shanghai East HospitalDiabetes

Start: 2021-09-01Updated: 2022-01-24

Phase 4

The effects, safety and pharmacokinetics of Ganglioside-Monosialic Acid (GM1) in patients with multiple myeloma

RecruitingChiCTR2000041283

Harbin Institute of Hematology and OncologyCIPN

Start: 2020-06-24Updated: 2021-03-08

Unknown Phase

Participate in the research on comprehensive early screening technology and clinical application of liver cancer and establish the application demonstration base of early screening and early diagnosis of liver disease in Shenzhen

RecruitingChiCTR2300067391

Shenzhen University General Hospitalliver cancer

Start: 2022-09-18Updated: 2023-05-15

Related Papers

Pharmacokinetics, safety, and efficacy of GM1 ganglioside in healthy subjects and patients with multiple myeloma: Two dose-escalation studies

European Journal of Pharmaceutical Sciences2023-08-141 citations